Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wilmott

Showing results (131-140 of 162) with videos related to

Pageof 17
Sort By:
Science Translational Medicine|December 16, 2016
The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor geneLéon C L van Kempen, Margaret Redpath, Mounib Elchebly, et al.
International Journal of Cancer|December 18, 2018
RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomesDajiang Guo, Goldie Y L Lui, Siew Li Lai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2020
Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanomaM T Tetzlaff, C Adhikari, S Lo, et al.
Nature Communications|May 17, 2022
Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomesManik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
Cancer Cell|February 13, 2019
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined TherapyTuba N Gide, Camelia Quek, Alexander M Menzies, et al.
Nature Communications|February 19, 2021
Tumour gene expression signature in primary melanoma predicts long-term outcomesManik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2020
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic MelanomaAilin Lepletier, Jason Madore, Jake S O'Donnell, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2015
Phylogenetic analyses of melanoma reveal complex patterns of metastatic disseminationJ Zachary Sanborn, Jongsuk Chung, Elizabeth Purdom, et al.
Genome Medicine|May 11, 2021
Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysisSunny Z Wu, Daniel L Roden, Ghamdan Al-Eryani, et al.
Nature Genetics|October 27, 2015
Recurrent inactivating RASA2 mutations in melanomaRand Arafeh, Nouar Qutob, Rafi Emmanuel, et al.
Pageof 17

Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Science Translational Medicine|December 16, 2016
The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor geneLéon C L van Kempen, Margaret Redpath, Mounib Elchebly, et al.
International Journal of Cancer|December 18, 2018
RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomesDajiang Guo, Goldie Y L Lui, Siew Li Lai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2020
Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanomaM T Tetzlaff, C Adhikari, S Lo, et al.
Nature Communications|May 17, 2022
Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomesManik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
Cancer Cell|February 13, 2019
Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined TherapyTuba N Gide, Camelia Quek, Alexander M Menzies, et al.
Nature Communications|February 19, 2021
Tumour gene expression signature in primary melanoma predicts long-term outcomesManik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2020
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic MelanomaAilin Lepletier, Jason Madore, Jake S O'Donnell, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2015
Phylogenetic analyses of melanoma reveal complex patterns of metastatic disseminationJ Zachary Sanborn, Jongsuk Chung, Elizabeth Purdom, et al.
Genome Medicine|May 11, 2021
Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysisSunny Z Wu, Daniel L Roden, Ghamdan Al-Eryani, et al.
Nature Genetics|October 27, 2015
Recurrent inactivating RASA2 mutations in melanomaRand Arafeh, Nouar Qutob, Rafi Emmanuel, et al.
Pageof 17